Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study

Acta Psychiatrica Scandinavica

Volumn 83, Issue 365 S, 1991, Pages 18-27

  Andersch, S ^a   Rosenberg, N K ^b   Kullingsjo H ^c   Ottosson, J O ^a   Bech, P ^d   Bruun Nansen J ^c   Hanson, L ^a   Lorentzen, K ^e   Mellergard M ^e   Rasmussen, S ^d   Rosenberg, R ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Rigshospitalet   (Denmark)

^c The Upjohn Company ^*  (Denmark)

^d Frederiksborgs Amts Centralsygehus Hillerød ^*  (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

alprazolam; anxiety; imipramine; panic disorder; placebo

Indexed keywords

ALPRAZOLAM; IMIPRAMINE; PLACEBO;

ADOLESCENT; ADULT; ANXIETY DISORDER; AROUSAL; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PANIC; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCANDINAVIA; ANXIETY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE;

ADOLESCENT; ADULT; ALPRAZOLAM; ANXIETY DISORDERS; AROUSAL; CHILD; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; HUMAN; IMIPRAMINE; MALE; MIDDLE AGE; PANIC; PERSONALITY TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCANDINAVIA;

EID: 0025930645     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1991.tb03097.x     Document Type: Article

References (20)

1. Die Agoraphobia eine neuropathische Er‐scheinung
2. Über die Berechtigung von dor Neurasthenic einen bestimmten Symptomcn‐complex als “Angstneurose” abzutrennen
3. Psychiatric reaction patterns to imi‐pramine
4. Research Diagnostic Criteria (RDC): rationale and reliability
5. One‐month prevalence of mental disorders in the U. S. based on five epidemiologic catchment area sites
6. Antidepressant drugs in anxietv disorders
7. Alprazolam in the treatment of generalized anxiety and panic disorders. A double‐blind, placebo‐controlled study
8. Current views on the treatment of panic and phobic disorders
9. Some biochemical correlates or panic attacks with agoraphobia and their response to a new treatment
10. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short‐term treatment
11. Drug treatment of panic disorders: comparative efficacy of alprazolam, imipramine and placebo
12. Alprazolam in panic disorder and agoraphobia: results from a multi‐center trial. I. Efficacy in short‐term treatment
13. The assessment of anxiety by rating
14. Brief standard self‐rating for phobic patients
15. A rating scale for depression
16. Treatment of phobic states with antidepressants
17. a technique for the systematic assessment of side effects in clinical trials
18. Applied relaxation vs. progressive relaxation in the treatment of panic disorder